16 results
POS AM
RAPH
Raphael Pharmaceutical Inc.
1 Jun 23
Prospectus update (post-effective amendment)
11:56am
at Rambam Health Care Campus, a member of the Executive Committee of the Israeli Society of Rheumatology, an active member of the Scleroderma Research Group
POS AM
RAPH
Raphael Pharmaceutical Inc.
1 Jun 23
Prospectus update (post-effective amendment)
11:55am
Unit at Rambam Health Care Campus, a member of the Executive Committee of the Israeli Society of Rheumatology, an active member of the Scleroderma
POS AM
RAPH
Raphael Pharmaceutical Inc.
4 May 23
Prospectus update (post-effective amendment)
4:01pm
Trials (Rambam) and Director of the B. Shine Rheumatology Unit at Rambam Health Care Campus, a member of the Executive Committee of the Israeli Society
POS AM
RAPH
Raphael Pharmaceutical Inc.
2 May 23
Prospectus update (post-effective amendment)
4:02pm
of the Israeli Society of Rheumatology, an active member of the Scleroderma Research Group (EUSTAR) and a member of the EULAR Target US initiative.
Dr. Shachar
POS AM
4q47b4e59ulbo1i1
26 May 22
Prospectus update (post-effective amendment)
9:28am
10-12G/A
jwlg7l3r
23 Sep 21
Registration of securities (amended)
6:19am
10-12G/A
a714ec0kd79b
2 Sep 21
Registration of securities (amended)
5:28pm
10-12G
er4rgm03ipz3ojqk clq
29 Jul 21
Registration of securities
12:00am
10-12G/A
ea5 257lei24
2 Jul 21
Registration of securities (amended)
4:15pm
10-12G
niykjc sv0
14 May 21
Registration of securities
5:27pm
- Prev
- 1
- Next